Kodiak Sciences reports positive topline results from BEACON Phase 3 study of tarcocimab in patients with retinal vein occlusion
Innovent announces first patient dosed in Phase 1 study of IBI324 in patients with diabetic macular edema
Rachitskaya: Archway found incidence of retinal fluid at Week 96 was generally comparable across treatment arms